
(Updates data on Biogen manufacturing plants in paragraph 18) Aug 11 (Reuters) – Global drugmakers are expanding their U.S. footprint, pledging billions of dollars to ramp up manufacturing capacity
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Cerebras to supply AI systems to cloud computing startup Gimlet Labs
By Max A. Cherney SAN FRANCISCO, Sept 28 (Reuters) - Cerebras Systems plans to supply…
SpaceX's Starship launches on 14th flight, first headed to orbit
By Joey Roulette STARBASE, Texas, Sept 28 (Reuters) - - SpaceX's next-generation Starship rocket lifted…
Tejas Wankhede — Turning Losses Into a Repeatable System for Commodity Trading Success
New Delhi [India], September 28: In the fast-moving world of commodity markets, very few educators…